
ACC 17 Research Wrap-Up: What Cardiologists Should Know
From moderate-risk TAVR to PCSK9 inhibitors to exercise in HCM, the American College of Cardiology’s annual Scientific Session brought advancements across many areas of cardiology.
March 19, 2017 8:00 PM